-Meda to Acquire Elidel for Usd420m

Summary


EQUITYBITES-(C)2011 M2 COMMUNICATIONS

Speciality pharma company Meda AB (STO:MEDAA) has today reached an agreement with Novartis to acquire global rights for Elidel (pimecrolimus 1% cream) for USD420m.

See the full content of this document

Extract


-Meda to Acquire Elidel for Usd420m

Elidel is a patent protected, specialty focused product for the...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company